HomeNRIX • NASDAQ
add
Nurix Therapeutics Inc
Previous close
$12.42
Day range
$12.08 - $12.56
Year range
$8.18 - $29.56
Market cap
932.30M USD
Avg Volume
929.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | May 2025info | Y/Y change |
|---|---|---|
Revenue | 44.06M | 264.34% |
Operating expense | 14.28M | 21.96% |
Net income | -43.46M | 2.43% |
Net profit margin | -98.66 | 73.22% |
Earnings per share | -0.52 | 26.76% |
EBITDA | -46.08M | 0.28% |
Effective tax rate | -1.78% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | May 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 485.78M | 9.62% |
Total assets | 591.56M | 15.76% |
Total liabilities | 143.95M | 2.58% |
Total equity | 447.60M | — |
Shares outstanding | 76.45M | — |
Price to book | 2.12 | — |
Return on assets | -20.02% | — |
Return on capital | -23.99% | — |
Cash Flow
Net change in cash
| (USD) | May 2025info | Y/Y change |
|---|---|---|
Net income | -43.46M | 2.43% |
Cash from operations | -63.16M | -59.08% |
Cash from investing | 71.50M | 154.55% |
Cash from financing | 6.00K | -100.00% |
Net change in cash | 8.34M | -87.54% |
Free cash flow | -45.89M | -70.54% |
About
Founded
2009
Headquarters
Website
Employees
286
